HEALTH● LOW4d ago · Aug 28, 2026, 11:24 AM
Lilly wins FDA label expansion for Mounjaro to reduce cardiovascular risk
Seeking Alpha Tech · north america
Eli Lilly's drug Mounjaro has received expanded approval from the FDA to reduce cardiovascular risk. This is an important development for patients and the medical field, potentially offering a new treatment option for heart health.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH26m agoBlood Bank of Delmarva Blood Drivewmdt.com · United StatesHEALTH41m agoJapan’s deadliest delicacy is getting more dangerousSouth China Morning PostHEALTH56m agoWhat it like to live with – and lose – a loved one with CTEwcvb.com · United StatesHEALTH1h agoAfrica grows more tobacco, spends more on imported cigarettes — WHOVanguard Nigeria